Digital [18F]FDG PET/CT as first-line diagnostic modality for cranial giant cell arteritis
European Journal of Nuclear Medicine and Molecular Imaging · 2026-11 · 53 (13) · 7705-7714
DOI: 10.1007/s00259-026-08131-7 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 21.08.2026. Verfasst von Gad Abikhzer und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Imaging, Jewish General Hospital, Montréal, Canada. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Giant Cell Arteritis, Positron Emission Tomography Computed Tomography. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Canadian Rheumatology Association.
Abstract (Originalsprache)
PURPOSE: Diagnosis of giant cell arteritis (GCA) is challenging and relies mainly on temporal artery biopsy and/or Doppler ultrasound (DUS). Although [18F]FDG PET/CT is the test of choice suspected large vessel (LV)-GCA, its use in cranial artery GCA (C-GCA) detection was previously limited. Digital PET/CT devices have improved resolution and sensitivity for smaller lesions. This international prospective cross-sectional comparative study investigates the diagnostic accuracy of digital PET/CT and DUS in patients with suspected GCA. METHODS: Patients aged ≥ 50 years with suspected GCA based on classical symptoms and inflammatory markers were enrolled. Exclusion criteria included corticosteroid therapy for > 3 days prior to PET/CT or prior history of vasculitis. PET/CT scans were interpreted independently by two blinded readers using standardized visual grading scales; in case of disagreement, a third blinded reader adjudicated. DUS of the temporal and axillary arteries was performed as standard of care. Temporal artery biopsy was performed at the treating physician's discretion. Final clinical diagnosis at 6 months served as reference standard. RESULTS: Of 92 enrolled subjects, 8 were excluded as they did not undergo DUS. Eighty-four subjects (mean age: 72 years; mean CRP: 70.7 mg/L) were included in the analysis with mean follow-up of 27 months (range 6-74). GCA was diagnosed in 44/84 patients. PET/CT sensitivity increased from 50.0% (95%CI: 34.6-65.4%) to 86.4% (95%CI: 72.7-94.8%) when incorporating C-GCA assessment, with specificity at 100.0% (95%CI: 91.2-100.0%). DUS demonstrated sensitivity 68.2% (95%CI: 52.4-81.4%) and specificity 92.5% (95%CI: 79.6-98.4%). CONCLUSION: Digital [18F]FDG PET/CT demonstrates high diagnostic accuracy for the diagnosis of C-GCA, supporting its potential role as a first-line modality in the evaluation of suspected GCA. TRIAL REGISTRATION NUMBER: NCT05000138. Trial registration date: 2021-08-03 (submission), 2022-06-10 (study start).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Imaging, Jewish General Hospital, Montréal, Canada.
- Department of Medical Imaging, Jewish General Hospital, Montréal, Canada. aubert.roy@mail.mcgill.ca.
- Department of Internal Medicine and Clinical Immunology, Referral Center for Rare Systemic Autoimmune and Autoinflammatory Diseases, Dijon-Bourgogne University Hospital, University EPE Bourgogne Europe, Dijon, France.
- Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Canada.
- Department of Medicine, Hôpital du Sacré-Coeur de Montréal, Vasculitis Clinic, University of Montréal, Montréal, Canada.
- Division of Rheumatology, Department of Medicine, McGill University, Montréal, Canada.
Förderung
- Canadian Rheumatology Association
Zitieren
APA
Abikhzer, G., Roy, A., Samson, M., Dendukuri, N., Makhzoum, J. P., Stein, M. A., Hudson, M., Rousseau, É., Nienhuis, P. H., Van der Geest, K. S. M., Pineau, C., Liang, P., Levin, L. A., Slart, R. H. J. A., & Alberini, J. L. (2026). Digital [18F]FDG PET/CT as first-line diagnostic modality for cranial giant cell arteritis. European Journal of Nuclear Medicine and Molecular Imaging, 53(13), 7705-7714. https://doi.org/10.1007/s00259-026-08131-7
Vancouver
Abikhzer G, Roy A, Samson M, Dendukuri N, Makhzoum JP, Stein MA, et al. Digital [18F]FDG PET/CT as first-line diagnostic modality for cranial giant cell arteritis. European Journal of Nuclear Medicine and Molecular Imaging. 2026;53(13):7705-7714. doi:10.1007/s00259-026-08131-7
BibTeX
@article{Abikhzer2026,
author = {Abikhzer, Gad and Roy, Aubert and Samson, Maxime and Dendukuri, Nandini and Makhzoum, Jean-Paul and Stein, Michael A and Hudson, Marie and Rousseau, Étienne and Nienhuis, Pieter H and Van der Geest, Kornelis S M and Pineau, Christian and Liang, Patrick and Levin, Leonard A and Slart, Riemer H J A and Alberini, Jean-Louis},
title = {Digital [18F]FDG PET/CT as first-line diagnostic modality for cranial giant cell arteritis},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2026},
volume = {53},
number = {13},
pages = {7705--7714},
doi = {10.1007/s00259-026-08131-7}
}
EUVIMED